Amit Mahipal

机构：University Hospitals of Cleveland, University Hospitals Seidman Cancer Center, Case Western Reserve University · ORCID：0000-0002-1111-8333

发表论文 474 篇 · 总被引 10084 次 · h-index 47

代表论文

• Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma (2025 · JCO Precision Oncology · 被引 15)
• Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma (2025 · Journal of Hepatology · 被引 11)
• Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 7)
• Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors (2025 · JAMA Network Open · 被引 7)
• First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study (2025 · The Oncologist · 被引 6)
• Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer (2026 · Journal for ImmunoTherapy of Cancer · 被引 2)